Remove Doctors Remove Drug Trials Remove Genetics Remove Medicine
article thumbnail

Personalising whole genome sequencing doubles diagnosis of rare diseases 

Drug Discovery World

In 2018, the UK’s department of health announced an NHS Genomic Medicine Service, which allows patients with rare diseases to have their entire genetic code read in the hope of providing a much-needed diagnosis. That said, some people with rare genetic diseases remain without a molecular diagnosis after their genome is analysed. . “We

Genome 52
article thumbnail

Fatty liver disease: With little early detection, more challenging drug development

pharmaphorum

That was until my doctors stunned me with the news that I had cirrhosis caused by non-alcoholic steatohepatitis, or NASH, a severe form of fatty liver disease that often has few or no symptoms until very late stages. That is a moral failure on the part of medicine. That makes recruitment of patients more challenging.

article thumbnail

Why Black People Remain Underrepresented in Clinical Trials

XTalks

Despite these statistics, in the US, Black people only constitute five percent of all clinical trial participants. The overwhelming majority of trial participants nationwide are white. Race-Based Medicine. However, the links between race-based genetics and disease are not quite clear. Personalized Medicine.